Literature DB >> 20376786

The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis.

Guo-Wei Zuo1, Christopher D Kohls, Bai-Cheng He, Liang Chen, Wenli Zhang, Qiong Shi, Bing-Qiang Zhang, Quan Kang, Jinyong Luo, Xiaoji Luo, Eric R Wagner, Stephanie H Kim, Farbod Restegar, Rex C Haydon, Zhong-Liang Deng, Hue H Luu, Tong-Chuan He, Qing Luo.   

Abstract

The CCN proteins contain six members, namely CCN1 to CCN6, which are small secreted cysteine-rich proteins. The CCN proteins are modular proteins, containing up to four functional domains. Many of the CCN members are induced by growth factors, cytokines, or cellular stress. The CCNs show a wide and highly variable expression pattern in adult and in embryonic tissues. The CCN proteins can integrate and modulate the signals of integrins, BMPs, VEGF, Wnts, and Notch. The involvement of integrins in mediating CCN signaling may provide diverse context-dependent responses in distinct cell types. CCN1 and CCN2 play an important role in development, angiogenesis and cell adhesion, whereas CCN3 is critical to skeletal and cardiac development. CCN4, CCN5 and CCN6 usually inhibit cell growth. Mutations of Ccn6 are associated with the progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia tarda. In stem cell differentiation, CCN1, CCN2, and CCN3 play a principal role in osteogenesis, chondrogenesis, and angiogenesis. Elevated expression of CCN1 is associated with more aggressive phenotypes of human cancer, while the roles of CCN2 and CCN3 in tumorigenesis are tumor type-dependent. CCN4, CCN5 and CCN6 function as tumor suppressors. Although CCN proteins may play important roles in fine-tuning other major signaling pathways, the precise function and mechanism of action of these proteins remain undefined. Understanding of the biological functions of the CCN proteins would not only provide insight into their roles in numerous cellular processes but also offer opportunities for developing therapeutics by targeting CCN functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376786      PMCID: PMC2922104          DOI: 10.14670/HH-25.795

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  107 in total

1.  CCN5 Expression in mammals. II. Adult rodent tissues.

Authors:  Mark R Gray; Jennifer A Malmquist; Matthew Sullivan; Michael Blea; John J Castellot
Journal:  J Cell Commun Signal       Date:  2007-11-13       Impact factor: 5.782

2.  Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.

Authors:  Takeshi Yanagita; Satoshi Kubota; Harumi Kawaki; Kazumi Kawata; Seiji Kondo; Teruko Takano-Yamamoto; Shinji Tanaka; Masaharu Takigawa
Journal:  FEBS J       Date:  2007-04       Impact factor: 5.542

3.  Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse.

Authors:  Mark Baguma-Nibasheka; Boris Kablar
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

4.  CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

Authors:  Snigdha Banerjee; Gopal Dhar; Inamul Haque; Suman Kambhampati; Smita Mehta; Krishanu Sengupta; Ossama Tawfik; Teresa A Phillips; Sushanta K Banerjee
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

5.  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Authors:  Cristiane G Lin; Shr-Jeng Leu; Ningyu Chen; Christopher M Tebeau; Shao-Xia Lin; Cho-Yau Yeung; Lester F Lau
Journal:  J Biol Chem       Date:  2003-04-13       Impact factor: 5.157

6.  CTGF inhibits BMP-7 signaling in diabetic nephropathy.

Authors:  Tri Q Nguyen; Peggy Roestenberg; Frans A van Nieuwenhoven; Niels Bovenschen; Zeke Li; Leon Xu; Noelynn Oliver; Jan Aten; Jaap A Joles; Cecilia Vial; Enrique Brandan; Karen M Lyons; Roel Goldschmeding
Journal:  J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 10.121

Review 7.  Functions and mechanisms of action of CCN matricellular proteins.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  Int J Biochem Cell Biol       Date:  2008-08-15       Impact factor: 5.085

8.  Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.

Authors:  Dong Xie; Dong Yin; Xiangjun Tong; James O'Kelly; Akio Mori; Carl Miller; Keith Black; Dorina Gui; Johathan W Said; H Phillip Koeffler
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

9.  NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells.

Authors:  Rajeev Gupta; Dengli Hong; Francisco Iborra; Samantha Sarno; Tariq Enver
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

10.  Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene.

Authors:  Emma Heath; Dalal Tahri; Elisabetta Andermarcher; Paul Schofield; Stewart Fleming; Catherine A Boulter
Journal:  BMC Dev Biol       Date:  2008-02-20       Impact factor: 1.978

View more
  43 in total

1.  Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.

Authors:  Bin Hu; Mohan S Nandhu; Hosung Sim; Paula A Agudelo-Garcia; Joshua C Saldivar; Claire E Dolan; Maria E Mora; Gerard J Nuovo; Susan E Cole; Mariano S Viapiano
Journal:  Cancer Res       Date:  2012-06-04       Impact factor: 12.701

2.  CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Authors:  Véronique Ouellet; Kerstin Tiedemann; Anna Mourskaia; Jenna E Fong; Danh Tran-Thanh; Eitan Amir; Mark Clemons; Bernard Perbal; Svetlana V Komarova; Peter M Siegel
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.

Authors:  Yogesh M Kulkarni; Emily Chambers; A J Robert McGray; Jason S Ware; Jonathan L Bramson; David J Klinke
Journal:  Integr Biol (Camb)       Date:  2012-07-09       Impact factor: 2.192

4.  Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation.

Authors:  Miljan Kuljanin; Gillian I Bell; Stephen E Sherman; Gilles A Lajoie; David A Hess
Journal:  Diabetologia       Date:  2017-07-14       Impact factor: 10.122

5.  First structural glimpse of CCN3 and CCN5 multifunctional signaling regulators elucidated by small angle x-ray scattering.

Authors:  Kenneth P Holbourn; Marc Malfois; K Ravi Acharya
Journal:  J Biol Chem       Date:  2011-05-04       Impact factor: 5.157

6.  A disintegrin and metalloprotease with thrombospondin type I motif 7: a new protease for connective tissue growth factor in hepatic progenitor/oval cell niche.

Authors:  Liya Pi; Marda Jorgensen; Seh-Hoon Oh; Yianni Protopapadakis; Altin Gjymishka; Alicia Brown; Paulette Robinson; Chuanju Liu; Edward W Scott; Gregory S Schultz; Bryon E Petersen
Journal:  Am J Pathol       Date:  2015-04-02       Impact factor: 4.307

Review 7.  The role of the CCN family of proteins in female reproduction.

Authors:  Elke Winterhager; Alexandra Gellhaus
Journal:  Cell Mol Life Sci       Date:  2014-01-22       Impact factor: 9.261

8.  CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.

Authors:  L Wu; C Runkle; H-J Jin; J Yu; J Li; X Yang; T Kuzel; C Lee; J Yu
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

9.  BMP9 signaling in stem cell differentiation and osteogenesis.

Authors:  Joseph D Lamplot; Jiaqiang Qin; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Justin Tomal; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  Am J Stem Cells       Date:  2013-03-08

10.  CCN1 (CYR61) and CCN3 (NOV) signaling drives human trophoblast cells into senescence and stimulates migration properties.

Authors:  Friederike Kipkeew; Manuela Kirsch; Diana Klein; Manuela Wuelling; Elke Winterhager; Alexandra Gellhaus
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.